Signal active
Organization
Contact Information
Overview
mybacs is a DTC, research-driven, Biotechnology company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.
About
E-Commerce, Biotechnology, Shopping, Health Care
2019
11-50
Headquarters locations
Zug, Zug, Switzerland, Europe
Social
Profile Resume
mybacs headquartered in Zug, Switzerland, Europe, operates in the E-Commerce, Biotechnology, Shopping, Health Care sector. The company focuses on E-Commerce and has secured $366.6M in funding across 48 round(s). With a team of 11-50 employees, mybacs is actively contributing to advancements in E-Commerce. Their latest funding round, Series A - mybacs, raised $5.9M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
5
0
$7.6M
Details
3
mybacs has raised a total of $7.6M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Seed | 778.0K | ||
2020 | Seed | 960.0K | ||
2023 | Early Stage Venture | 5.9M |
Investors
mybacs is funded by 13 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
WENVEST Capital | - | FUNDING ROUND - WENVEST Capital | 5.9M |
Joyance Partners | - | FUNDING ROUND - Joyance Partners | 5.9M |
mybacs | - | FUNDING ROUND - mybacs | 5.9M |
SevenVentures | - | FUNDING ROUND - SevenVentures | 5.9M |